Cargando…

Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis

Lockdown due to the Coronavirus disease 2019 (COVID 19) pandemic may cause weight gain and enhance the risk of type 2 diabetes mellitus (T2DM). We aimed to determine this risk in apparently non-diabetic individuals. MATERIAL METHODS: Baseline demographic and clinical data from 100 apparently non-dia...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosal, Samit, Arora, Bhavya, Dutta, Koel, Ghosh, Amerta, Sinha, Binayak, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303633/
https://www.ncbi.nlm.nih.gov/pubmed/32604013
http://dx.doi.org/10.1016/j.dsx.2020.06.020
_version_ 1783548100495802368
author Ghosal, Samit
Arora, Bhavya
Dutta, Koel
Ghosh, Amerta
Sinha, Binayak
Misra, Anoop
author_facet Ghosal, Samit
Arora, Bhavya
Dutta, Koel
Ghosh, Amerta
Sinha, Binayak
Misra, Anoop
author_sort Ghosal, Samit
collection PubMed
description Lockdown due to the Coronavirus disease 2019 (COVID 19) pandemic may cause weight gain and enhance the risk of type 2 diabetes mellitus (T2DM). We aimed to determine this risk in apparently non-diabetic individuals. MATERIAL METHODS: Baseline demographic and clinical data from 100 apparently non-diabetic household members (related or unrelated) of patients with type 2 diabetes mellitus were collected until 49 days of lockdown and analyzed using the XL-STAT statistical software. A two-pronged analytical strategy was employed. First, the metabolic risk profile related to age, sex, weight, family history, and exercise pattern was analyzed. This was followed by an assessment of the risk of developing type 2 diabetes using an established risk assessment engine. RESULTS: There was a trend towards weight gain seen in 40% of the cohort, with 16% of the population experiencing a 2.1–5 kg weight increment. When all the risk parameters were analyzed together using the ADA risk engine, there was an increase in the ADA diabetes risk score in 7% of the population, with 6.66% in the high-risk group. There was a further increase in weight among 3% of the population who were already obese at baseline. CONCLUSION: We show an increased risk of T2MD consequent to weight gain during 49 days of lockdown in India.
format Online
Article
Text
id pubmed-7303633
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Diabetes India. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-73036332020-06-19 Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis Ghosal, Samit Arora, Bhavya Dutta, Koel Ghosh, Amerta Sinha, Binayak Misra, Anoop Diabetes Metab Syndr Article Lockdown due to the Coronavirus disease 2019 (COVID 19) pandemic may cause weight gain and enhance the risk of type 2 diabetes mellitus (T2DM). We aimed to determine this risk in apparently non-diabetic individuals. MATERIAL METHODS: Baseline demographic and clinical data from 100 apparently non-diabetic household members (related or unrelated) of patients with type 2 diabetes mellitus were collected until 49 days of lockdown and analyzed using the XL-STAT statistical software. A two-pronged analytical strategy was employed. First, the metabolic risk profile related to age, sex, weight, family history, and exercise pattern was analyzed. This was followed by an assessment of the risk of developing type 2 diabetes using an established risk assessment engine. RESULTS: There was a trend towards weight gain seen in 40% of the cohort, with 16% of the population experiencing a 2.1–5 kg weight increment. When all the risk parameters were analyzed together using the ADA risk engine, there was an increase in the ADA diabetes risk score in 7% of the population, with 6.66% in the high-risk group. There was a further increase in weight among 3% of the population who were already obese at baseline. CONCLUSION: We show an increased risk of T2MD consequent to weight gain during 49 days of lockdown in India. Diabetes India. Published by Elsevier Ltd. 2020 2020-06-19 /pmc/articles/PMC7303633/ /pubmed/32604013 http://dx.doi.org/10.1016/j.dsx.2020.06.020 Text en © 2020 Diabetes India. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ghosal, Samit
Arora, Bhavya
Dutta, Koel
Ghosh, Amerta
Sinha, Binayak
Misra, Anoop
Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
title Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
title_full Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
title_fullStr Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
title_full_unstemmed Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
title_short Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis
title_sort increase in the risk of type 2 diabetes during lockdown for the covid19 pandemic in india: a cohort analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303633/
https://www.ncbi.nlm.nih.gov/pubmed/32604013
http://dx.doi.org/10.1016/j.dsx.2020.06.020
work_keys_str_mv AT ghosalsamit increaseintheriskoftype2diabetesduringlockdownforthecovid19pandemicinindiaacohortanalysis
AT arorabhavya increaseintheriskoftype2diabetesduringlockdownforthecovid19pandemicinindiaacohortanalysis
AT duttakoel increaseintheriskoftype2diabetesduringlockdownforthecovid19pandemicinindiaacohortanalysis
AT ghoshamerta increaseintheriskoftype2diabetesduringlockdownforthecovid19pandemicinindiaacohortanalysis
AT sinhabinayak increaseintheriskoftype2diabetesduringlockdownforthecovid19pandemicinindiaacohortanalysis
AT misraanoop increaseintheriskoftype2diabetesduringlockdownforthecovid19pandemicinindiaacohortanalysis